Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

1:05 PM ET 8-K
Capital Raise Cottonwood Communities, Inc.

Cottonwood Communities Capital Raise

Cottonwood Communities, Inc. reported an unregistered sale of equity securities under Item 3.02. This typically indicates a private placement or issuance of shares to investors or counterparties without a public offering.

12:12 PM ET 8-K
M&A Deal ONE Nuclear Energy Inc. ONEN

Hennessy Capital Investment Corp. VII M&A Deal with ONE Nuclear Energy LLC

Hennessy Capital Investment Corp. VII (HVII) entered into a forward purchase agreement with New Circle Capital Solutions LP to support its pending merger with ONE Nuclear Energy LLC. The agreement allows for the purchase of up to 5,000,000 shares to mitigate potential redemptions and ensure funding for the business combination. This filing serves as a status and structural update for the previously announced M&A transaction.

Counterparty
ONE Nuclear Energy LLC
9:24 AM ET 8-K
Contract Win Blackberry Ltd BB

Blackberry Wins $100M Contract from Coretura

BlackBerry's QNX division and Vector Informatik secured a major design win with Coretura, a software-defined vehicle joint venture between Daimler Truck and Volvo Group. The deal adds over $100 million to the QNX royalty backlog and represents the largest design win in QNX history, utilizing the jointly developed Alloy Kore foundational vehicle OS.

Value
$100M
Counterparty
Coretura
9:22 AM ET 8-K
Capital Raise Brand Engagement Network Inc. BNAI

Brand Engagement Network Capital Raise of $1.05M

Brand Engagement Network Inc. entered into a securities purchase agreement for a $1.05 million private placement of 123,650 shares of common stock at $8.50 per share. The offering price represents a premium of more than 20% to the company's recent closing price and includes 100% warrant coverage. Proceeds will be funded in tranches, with an initial $150,025 at closing and the remainder in five monthly installments through February 2027.

Value
$1.05M
Counterparty
BEN Capital Fund I, LLC and Joseph Bevash
Term
through February 2027

“This is another above-market commitment from investors who already know the company — after Cataneo, after Accelevate, and while we continue to deploy enterprise AI. The people writing the checks are not trading the noise. They are funding the plan.”

Tyler Luck, Chief Executive Officer of Brand Engagement Network
9:14 AM ET 8-K
M&A Deal Caesars Entertainment, Inc. CZR

Caesars Entertainment M&A Deal with Fertitta Gaming Holdco, LLC

Caesars Entertainment provided a status update on its pending merger with Fertitta Gaming Holdco, LLC, specifically addressing a stockholder demand letter alleging disclosure omissions in the proxy statement. To avoid potential delays to the merger timeline, the company issued supplemental disclosures regarding its legal counsel's unrelated work for Tilman J. Fertitta's affiliates.

Counterparty
Fertitta Gaming Holdco, LLC
8:32 AM ET 8-K
Clinical Trial Data bioAffinity Technologies, Inc. BIAF

bioAffinity Technologies Clinical Trial Data

bioAffinity Technologies is presenting clinical data and research updates for its CyPath Lung diagnostic at the 2026 NAVREF Annual Conference. The presentations include clinical case studies demonstrating how the test prevents unnecessary invasive procedures and an update on the 2,000-patient FlowPath Lung longitudinal study involving veterans and military personnel.

Counterparty
National Association of Veterans’ Research and Education Foundations (NAVREF)
8:32 AM ET 8-K
M&A Deal Xflh Capital Corp XFLH

Xflh Capital M&A Deal with Renogen Biolab Inc.

XFLH Capital Corporation, a SPAC, has signed a non-binding letter of intent for a business combination with Renogen Biolab Inc., a Canadian health service provider specializing in molecular capabilities such as DNA services and vector engineering. The parties are now working to negotiate definitive agreements and conduct mutual due diligence to finalize the merger.

Counterparty
Renogen Biolab Inc.
8:05 AM ET 8-K
Clinical Trial Data PDS Biotechnology Corp PDSB

PDS Biotechnology Clinical Trial Data

PDS Biotechnology announced the publication of Phase 2 VERSATILE-002 trial results in JAMA Oncology, evaluating PDS0101 in combination with pembrolizumab for HPV16-positive head and neck cancer. The study reported a median overall survival of 39.3 months in ICI-naïve patients, significantly exceeding the 17.9 months typically seen with standard-of-care pembrolizumab. The treatment was well-tolerated with a 13.8% rate of Grade 3 or higher treatment-related adverse events.

Counterparty
JAMA Oncology
7:56 AM ET 8-K
M&A Deal Iron Horse Acquisition II Corp. IRHO

Iron Horse Acquisition II Signs $250M M&A Deal with Electra Vehicles, Inc.

Iron Horse Acquisition II Corp. (IRHO) provided a status update on its pending merger with Electra Vehicles, Inc., a transaction valued at over $250 million. The update highlights commercial milestones achieved since the April 2026 agreement, including new partnerships with Mooving, Omega Seiki Mobility, and Propel Industries, as the companies work toward a closing in the second half of 2026.

Value
$250M
Counterparty
Electra Vehicles, Inc.
7:31 AM ET 8-K
M&A Deal Beam Global BEEM

Beam Global M&A Deal with Unnamed European drone technology company

Beam Global has signed a non-binding letter of intent to acquire a European drone technology company that develops AI-enhanced software and hardware. If completed, Beam intends to manufacture the target's U.S. Department of War conditionally approved drone systems in its existing U.S. and European factories. The deal aims to transform Beam into a vertically integrated drone and software provider, leveraging its existing battery manufacturing expertise and government customer base.

Counterparty
Unnamed European drone technology company
7:30 AM ET 8-K
Contract Win Greenbrier Companies Inc GBX

Greenbrier Companies Wins $600M Contract from Saudi Railway Company

Greenbrier Companies announced orders for 3,400 new railcars valued at approximately $600 million during its fiscal fourth quarter. The orders include 780 units for the Saudi Railway Company (SAR), marking Greenbrier's first sale of intermodal units to SAR and expanding their long-term infrastructure partnership in Saudi Arabia.

Value
$600M
Counterparty
Saudi Railway Company (SAR)
7:12 AM ET 8-K
Capital Raise Willis Lease Finance Corp WLFC

Willis Lease Finance Capital Raise of $35M

Willis Lease Finance Corporation entered into a purchase agreement to issue 1,750,000 shares of newly issued 8.09% Series B Preferred Stock to the Development Bank of Japan Inc. in a private placement. The transaction is expected to generate gross proceeds of approximately $35 million to support the company's global aviation services platform and business growth.

Value
$35M
Counterparty
Development Bank of Japan Inc.
7:09 AM ET 8-K
M&A Deal Lexeo Therapeutics, Inc. LXEO

Lexeo Therapeutics Signs $8.3M M&A Deal with Mantle Therapeutics Inc.

Lexeo Therapeutics entered into a definitive agreement to acquire Mantle Therapeutics for an upfront purchase price of $5.3 million in cash and $3.0 million in common stock. The deal includes up to $12.0 million in contingent development and regulatory milestone payments plus a $1.0 million cash payment upon specific events, aimed at expanding Lexeo's Friedreich ataxia (FA) pipeline with new CNS-targeted modalities.

Value
$8.3M
Counterparty
Mantle Therapeutics Inc.
7:09 AM ET 8-K
Clinical Trial Data Celldex Therapeutics, Inc. CLDX

Celldex Therapeutics Clinical Trial Data

Celldex reported positive topline results from its Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 trials of barzolvolimab in chronic spontaneous urticaria (CSU), meeting the primary and all key secondary endpoints. The data showed rapid and sustained efficacy through 24 weeks, including in patients refractory to omalizumab, with a favorable safety profile. The company plans to submit a Biologics License Application (BLA) to the FDA in 2027.

Earnings call
Sep 22, 2026, 8:00 AM ET

“The results from our two Phase 3 EMBARQ-CSU trials showed efficacy that is best-in-disease in CSU. We believe barzolvolimab is well-positioned to address large CSU populations of high unmet need—as a first-line therapy for patients with severe CSU or angioedema, and as the second-line advanced therapy of choice.”

Anthony Marucci, Co-Founder, President, and Chief Executive Officer at Celldex

“Barzolvolimab continued to show unprecedented complete response rates across the overall studies and demonstrated strong differentiation in patient populations underserved by existing therapies, including those with severe disease or angioedema, and those whose disease is refractory to omalizumab.”

Diane Young, MD, Senior Vice President and Chief Medical Officer of Celldex
7:09 AM ET 8-K
M&A Deal Ligand Pharmaceuticals Inc LGND

Ligand Pharmaceuticals Signs $23M M&A Deal with Sydnexis, Inc.

Ligand Pharmaceuticals acquired royalty and milestone payment rights for Ryjunea from Sydnexis for $23 million upfront. Ryjunea is a treatment for pediatric myopia licensed to Santen Pharmaceutical in the EMEA region, where it is already approved. Ligand will receive tiered royalties ranging from low-double-digits to high-teens on net sales in those territories.

Value
$23M
Counterparty
Sydnexis, Inc.
7:06 AM ET 8-K
Clinical Trial Data Viking Therapeutics, Inc. VKTX

Viking Therapeutics Clinical Trial Data

Viking Therapeutics announced positive topline results from a maintenance study of its GLP-1/GIP agonist VK2735, demonstrating that less frequent dosing (monthly and every other week) effectively maintained weight loss. Subjects receiving weekly 17.5 mg doses achieved 22% placebo-adjusted weight loss at Week 33, and the drug showed excellent tolerability with GI adverse event rates similar to placebo during the maintenance phase.

Earnings call
Sep 29, 2026, 8:00 AM ET

“The results of our innovative maintenance dosing study continue to demonstrate the significance of VK2735’s unique and differentiated half-life and PK profile, which appear to enable an effective new approach to achieving and maintaining the weight loss goals of patients living with obesity.”

Brian Lian, Ph.D., chief executive officer of Viking

“We believe this dose-ranging study clearly demonstrated the potential viability of novel, extended dosing approaches for maintenance following induction with an incretin-based therapy.”

Brian Lian, Ph.D., chief executive officer of Viking
7:02 AM ET 8-K
M&A Deal Cognex Corp CGNX

Cognex Signs $500M M&A Deal with RealSense, Inc.

Cognex Corporation has entered into a definitive agreement to acquire RealSense, Inc., a leader in 3D depth-sensing cameras and robotic perception technology, for $500 million in cash. The deal expands Cognex's presence in the high-growth robotic perception and Physical AI markets and is expected to close in the fourth quarter of 2026. Cognex will also implement retention packages for RealSense employees consisting of approximately $50 million in RSUs and up to $69 million in cash payments over three years.

Value
$500M
Counterparty
RealSense, Inc.
Earnings call
Sep 22, 2026, 8:00 AM ET

“RealSense represents a compelling strategic expansion for Cognex into robotic perception, one of the most attractive adjacent markets in machine vision. RealSense brings a leading 3D perception platform with proprietary technology, a strong developer community and a compelling value proposition for customers. Combined with Cognex’s machine vision expertise and global reach, RealSense positions us to offer a full-stack visual intelligence platform, spanning industrial ID, 2D and 3D machine vision measurement to 3D depth perception and robotic navigation, built to serve the full spectrum of Physical AI.”

Matt Moschner, President and Chief Executive Officer of Cognex

“RealSense was built on a simple idea: robots and autonomous systems can’t act intelligently in the physical world if they can’t first perceive it accurately. We’ve called that mission the Visual Cortex of Physical AI. Joining Cognex puts that mission on an entirely new scale, giving us access to a global industrial customer base and go-to-market reach that would have taken us years to build on our own. This is a combination that makes both businesses stronger.”

Nadav Orbach, Chief Executive Officer of RealSense
6:54 AM ET 8-K
Capital Raise Circle Internet Group, Inc. CRCL

Circle Internet Group Capital Raise of $100M

Circle Internet Group issued 1,237,011 shares of Class A common stock to Binance in a private placement for $100 million. Concurrently, the companies expanded their strategic partnership for a five-year term, where Circle will pay Binance incentive fees to promote USDC through Circle's Modular Smart Contract Wallet infrastructure.

Value
$100M
Counterparty
Binance
Term
5 years
6:09 AM ET 8-K
Capital Raise Elmet Group Co. ELMT

Elmet Group Capital Raise

The Elmet Group Co. entered into a warrant purchase agreement with Blue Moon Metals Inc., issuing a warrant to purchase up to 1,166,970 shares of common stock at an exercise price of $21.423 per share. The issuance is in consideration for Blue Moon's strategic investment and obligations under a previously disclosed binding letter agreement. The warrants are exercisable for three years starting six months from the date of issuance.

Counterparty
Blue Moon Metals Inc.
Term
3 years
6:06 AM ET 8-K/A
Capital Raise Host Digital Inc. HOST

Host Digital Capital Raise

Host Digital Inc. filed an amendment to a previous 8-K to correct the name of an underwriter in its underwriting agreement with Cantor Fitzgerald & Co. The filing relates to an ongoing equity offering, though specific proceeds and share counts were not disclosed in this administrative amendment.

Counterparty
Cantor Fitzgerald & Co.
6:02 AM ET 8-K
Capital Raise abrdn Global Infrastructure Income Fund ASGI

abrdn Global Infrastructure Income Fund Capital Raise

abrdn Global Infrastructure Income Fund has commenced a transferable rights offering, allowing shareholders to subscribe for up to 10,545,755 new common shares. Shareholders of record will receive one right for every share held, with three rights required to purchase one new share. The fund entered into a dealer manager agreement with UBS Securities LLC to facilitate the offering, which is scheduled to expire on October 15, 2026.

Counterparty
UBS Securities LLC
6:02 AM ET 8-K
M&A Deal Blue Acquisition Corp BACC

Blue Acquisition M&A Deal with Blockfusion USA, Inc.

Blue Acquisition Corp. entered into a sixth amendment to its definitive business combination agreement with Blockfusion USA, Inc. to revise the deal structure. The amendment increases the maximum earnout shares to 15 million based on stock price thresholds of $13, $15, and $17, and adjusts the treatment of a warrant held by CoreWeave, Inc. to be exchanged for Pubco shares upon closing.

Counterparty
Blockfusion USA, Inc.
5:21 PM ET 8-K
Divestiture Generation Income Properties, Inc. GIPR

Generation Income Properties Divestiture to DDF Candor, LLC for $5.28M

Generation Income Properties completed the disposition of multiple net-leased properties, including a Fresenius-occupied medical property in Chicago for $2.8 million and a government-occupied property in Vacaville for $2.475 million. The company also reacquired a 7-Eleven property in Washington, D.C. from Brown Family Enterprises for $0.6 million in cash and the termination of a prior satisfaction agreement. These transactions are part of a broader portfolio restructuring that includes the sale of six Dollar General properties.

Value
$5.28M
Counterparty
DDF Candor, LLC
5:18 PM ET 8-K
M&A Deal Vista Gold Corp VGZ

Vista Gold Signs $427M M&A Deal with Artemis Gold Inc.

Vista Gold Corp. has entered into a definitive agreement to be acquired by Artemis Gold Inc. in an all-stock transaction valued at approximately $427 million. Vista shareholders will receive 0.0966 Artemis shares for each Vista share, representing a 29% premium, to gain control of the Mt Todd gold project in Australia.

Value
$427M
Counterparty
Artemis Gold Inc.
Earnings call
Sep 21, 2026, 11:00 AM ET
5:17 PM ET 8-K
M&A Deal Algorhythm Holdings, Inc. RIME

Algorhythm Holdings Signs $23M M&A Deal with Azure Energy, LLC

Algorhythm Holdings acquired substantially all assets of Azure Energy, LLC for $23 million in stock, marking a strategic pivot into renewable energy infrastructure. The deal includes inventory, intellectual property, and real property related to converting waste and biomass into clean power. In connection with the acquisition, the company dismissed long-time CEO Gary Atkinson as part of a broader leadership and board transition.

Value
$23M
Counterparty
Azure Energy, LLC
5:16 PM ET 8-K
Divestiture Woodward, Inc. WWD

Woodward Divestiture

Woodward, Inc. is transitioning production out of its Santa Clarita, California facility, moving military flight control actuation production to its new Spartanburg, South Carolina campus. As part of this footprint refinement, the company has agreed to sell the Santa Clarita campus along with legacy commercial rotorcraft, land systems, and business jet product lines. The company expects to recognize pre-tax charges between $34 million and $47.5 million related to severance and contract terminations through December 2027.

Term
through Dec 2027
5:09 PM ET 8-K
Divestiture Hawaiian Electric Industries Inc HE

Hawaiian Electric Industries Divestiture to American Savings Bank, N.A. for $33.9M

Hawaiian Electric Industries (HEI) monetized a portion of its 9.9% stake in American Savings Bank (ASB) during ASB's initial public offering, selling approximately 2.3 million shares for total net proceeds of $33.9 million. The proceeds, which include the full exercise of the underwriters' overallotment option, will be used to fund Maui wildfire settlement payments and strengthen HEI's liquidity. HEI retains a 6.4% stake in ASB valued at approximately $73.5 million, which is subject to a 180-day lockup period.

Value
$33.9M
Counterparty
American Savings Bank, N.A.
5:05 PM ET 8-K
Capital Raise Generation Income Properties, Inc. GIPR

Generation Income Properties Capital Raise of $4.28M

Generation Income Properties entered into an inducement agreement with an investor to exercise outstanding warrants for 4,074,359 shares at a reduced price of $1.05 per share. The transaction generated approximately $4.3 million in gross proceeds and included the issuance of 8,148,718 new unregistered 'reload' warrants as an incentive. The company intends to use the proceeds for general corporate purposes and will seek shareholder approval for the new warrants.

Value
$4.28M
5:04 PM ET 8-K
M&A Deal IB Acquisition Corp. IBAC

IB Acquisition Signs $50M M&A Deal with GNQ Insilico, Inc.

IB Acquisition Corp. entered into a $50 million equity purchase facility with an institutional investor to provide capital following its pending business combination with GNQ Insilico, Inc. The facility allows the company to sell shares of Class A common stock over a 36-month period to support the post-merger entity, which will trade under the symbol GNQI.

Value
$50M
Counterparty
GNQ Insilico, Inc.
Term
36 months
5:02 PM ET 8-K
M&A Deal Axos Financial, Inc. AX

Axos Financial Signs $1.9B M&A Deal with Capital One, National Association

Axos Bank, a subsidiary of Axos Financial, Inc., completed its acquisition of approximately $1.9 billion in individual retirement account (IRA) deposits from Capital One. The transaction was finalized under a previously announced Purchase and Assumption Agreement, with Axos receiving cash for the aggregate deposit balance less a negotiated premium.

Value
$1.9B
Counterparty
Capital One, National Association

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.